Yantai Zhenghai Bio-Tech Co Ltd (300653) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.035x

Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥30.47 Million ≈ $4.46 Million USD) by net assets (CN¥874.47 Million ≈ $127.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yantai Zhenghai Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Yantai Zhenghai Bio-Tech Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Yantai Zhenghai Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MiCo Ltd
KQ:059090
0.027x
Shenzhen Keanda Electronic Techno
SHE:002972
0.002x
Gansu Dunhuang Seed Co Ltd
SHG:600354
0.178x
Guangdong Guanghong Holdings Co Ltd
SHE:000529
-0.001x
ACNB Corporation
NASDAQ:ACNB
0.030x
Shandong Meichen Science & Technology Co Ltd
SHE:300237
0.078x
Shenzhen Huakong Seg Co Ltd
SHE:000068
0.085x
S.C. CHIMCOMPLEX S.A.
RO:CRC
-0.008x

Annual Cash Flow Conversion Efficiency for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Yantai Zhenghai Bio-Tech Co Ltd (300653) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥888.78 Million
≈ $130.06 Million
CN¥151.38 Million
≈ $22.15 Million
0.170x -10.53%
2023-12-31 CN¥948.07 Million
≈ $138.73 Million
CN¥180.48 Million
≈ $26.41 Million
0.190x -12.33%
2022-12-31 CN¥865.11 Million
≈ $126.59 Million
CN¥187.84 Million
≈ $27.49 Million
0.217x +2.63%
2021-12-31 CN¥785.27 Million
≈ $114.91 Million
CN¥166.13 Million
≈ $24.31 Million
0.212x +15.53%
2020-12-31 CN¥646.72 Million
≈ $94.64 Million
CN¥118.43 Million
≈ $17.33 Million
0.183x +4.13%
2019-12-31 CN¥588.38 Million
≈ $86.10 Million
CN¥103.48 Million
≈ $15.14 Million
0.176x +20.10%
2018-12-31 CN¥529.00 Million
≈ $77.41 Million
CN¥77.47 Million
≈ $11.34 Million
0.146x +8.07%
2017-12-31 CN¥483.18 Million
≈ $70.70 Million
CN¥65.47 Million
≈ $9.58 Million
0.136x -37.22%
2016-12-31 CN¥228.16 Million
≈ $33.39 Million
CN¥49.25 Million
≈ $7.21 Million
0.216x -15.34%
2015-12-31 CN¥179.40 Million
≈ $26.25 Million
CN¥45.74 Million
≈ $6.69 Million
0.255x -47.32%
2014-12-31 CN¥63.62 Million
≈ $9.31 Million
CN¥30.79 Million
≈ $4.51 Million
0.484x -58.71%
2013-12-31 CN¥29.34 Million
≈ $4.29 Million
CN¥34.38 Million
≈ $5.03 Million
1.172x +133.32%
2012-12-31 CN¥-6.43 Million
≈ $-941.02K
CN¥22.62 Million
≈ $3.31 Million
-3.517x --

About Yantai Zhenghai Bio-Tech Co Ltd

SHE:300653 China Biotechnology
Market Cap
$483.33 Million
CN¥3.30 Billion CNY
Market Cap Rank
#12709 Global
#3966 in China
Share Price
CN¥18.35
Change (1 day)
-1.45%
52-Week Range
CN¥18.05 - CN¥23.13
All Time High
CN¥53.33
About

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more